Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4780734
Max Phase: Preclinical
Molecular Formula: C51H68N12O10S2
Molecular Weight: 1073.31
Molecule Type: Unknown
Associated Items:
ID: ALA4780734
Max Phase: Preclinical
Molecular Formula: C51H68N12O10S2
Molecular Weight: 1073.31
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1)C(N)=O
Standard InChI: InChI=1S/C51H68N12O10S2/c1-28(2)43(44(55)66)63-51(73)41-27-75-74-26-40(61-45(67)34(53)19-20-42(54)65)50(72)59-37(22-29-10-4-3-5-11-29)47(69)60-39(24-31-25-56-35-13-7-6-12-33(31)35)49(71)57-36(14-8-9-21-52)46(68)58-38(48(70)62-41)23-30-15-17-32(64)18-16-30/h3-7,10-13,15-18,25,28,34,36-41,43,56,64H,8-9,14,19-24,26-27,52-53H2,1-2H3,(H2,54,65)(H2,55,66)(H,57,71)(H,58,68)(H,59,72)(H,60,69)(H,61,67)(H,62,70)(H,63,73)/t34-,36-,37-,38-,39-,40-,41-,43-/m0/s1
Standard InChI Key: QUDWCKAHALLUIE-MXGZSICKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1073.31 | Molecular Weight (Monoisotopic): 1072.4623 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Bandholtz S,Erdmann S,von Hacht JL,Exner S,Krause G,Kleinau G,Grötzinger C. (2016) Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist., 59 (22.0): [PMID:27791374] [10.1021/acs.jmedchem.6b00164] |
Source(1):